{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:21:05Z","timestamp":1787026865075,"version":"build-2736575974"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"DOI":"10.3389\/fnut.2020.00057","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T01:20:32Z","timestamp":1588209632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Postoperative Adjuvant Chemotherapy Regimen of CAPOX Combined With Ninjin'yoeito in an Elderly Patient With Stage III Colon Cancer: A Case Report"],"prefix":"10.3389","volume":"7","author":[{"given":"Naoki","family":"Aomatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutake","family":"Uchima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Tsujio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Matsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Iwauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehito","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tachimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11418-015-0921-9","article-title":"Ninjin'yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells","volume":"69","author":"Suzuki","year":"2015","journal-title":"J Nat Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fphar.2018.01400","article-title":"Effect of ninjin'yoeito on the loss of skeletal muscle function in cancer-bearing mice","volume":"9","author":"Ohsawa","year":"2018","journal-title":"Front Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnut.2018.00093","article-title":"Multifunctional actions of Ninjinyoeito, a Japanese kampo medicine: accumulated scientific evidence based on experiments with cells and animal models, and clinical studies","volume":"5","author":"Miyano","year":"2018","journal-title":"Front Nutr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s11418-017-1113-6","article-title":"Effect of ninjin'yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice","volume":"71","author":"Suzuki","year":"2017","journal-title":"J Nat Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJM199002083220602","article-title":"Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma","volume":"322","author":"Moertel","year":"1990","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andre","year":"2004","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1200\/JCO.2015.60.9107","article-title":"Capecitabine plus oxaliplatin compared with fluorouracil\/folinic acid as adjuvant therapy for stage iii colon cancer: final results of the NO16968 Randomized Controlled Phase III Trial","volume":"33","author":"Schmoll","year":"2015","journal-title":"J Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.7326\/0003-4819-136-5-200203050-00007","article-title":"Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer","volume":"136","author":"Sundararajan","year":"2002","journal-title":"Ann Intern Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.2010.30.0855","article-title":"Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08","volume":"29","author":"Allegra","year":"2011","journal-title":"J Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1056\/NEJMoa043116","article-title":"Capecitabine as adjuvant treatment for stage III colon cancer","volume":"352","author":"Twelves","year":"2005","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1470-2045(12)70509-0","article-title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial","volume":"13","author":"de Gramont","year":"2012","journal-title":"Lancet Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/annonc\/mdv003","article-title":"Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials","volume":"26","author":"Haller","year":"2015","journal-title":"Ann Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage iii colon cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andre","year":"2009","journal-title":"J Clin Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0093-7754(03)00399-3","article-title":"Oxaliplatin-safety profile: neurotoxicity","volume":"30","author":"Grothey","year":"2003","journal-title":"Semin Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ejca.2011.08.009","article-title":"Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents","volume":"48","author":"Ushio","year":"2012","journal-title":"Eur J. Cancer."},{"key":"B17","first-page":"183","article-title":"Involvement of descending monoaminergic systems in antiallodynic effect of goshajinkigan in oxaliplatin-treated mice","volume":"30","author":"Kitamura","year":"2013","journal-title":"J Trad Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"13244FP","DOI":"10.1254\/jphs.13244FP","article-title":"Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat","author":"Mizuno","year":"2014","journal-title":"J Pharmacol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10147-015-0784-9","article-title":"Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study","volume":"20","author":"Oki","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"B20","first-page":"454","article-title":"Igan Jutsugo hozyokagakuryouhou ni okeru Ninjin'yoeito no yuuyouseini kannsuru kennkyuu (Study of efficacy of Ninjin Yoei-to for adjuvant chemotherapy after gastric cancer surgery)","volume":"72","author":"Sugimachi","year":"1995","journal-title":"Jpn J Clin Exp Med"},{"key":"B21","first-page":"2855","article-title":"Jutsugo hojokagakuryouhou ni okeru Ninjin Yoei-to no yuuyousei ni kannsurukennkyuu (Experience of use of Ninjin Yoei-to in postoperative maintenance chemotherapy)","volume":"10","author":"Abe","year":"1990","journal-title":"Progress Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/ecam\/nem080","article-title":"Oral administration of Ren-shen-yang-rong-tang 'ninjin'yoeito'protects against hematotoxicity and induces immature erythroid progenitor cells in 5-fluorouracil-induced anemia","volume":"6","author":"Takano","year":"2009","journal-title":"Evid Based Complement Alternat Med."},{"key":"B23","first-page":"251","article-title":"Kampo medicine for the treatment of adverse effects caused by anticancer drugs","volume":"114","author":"Kono","year":"2013","journal-title":"Nihon Geka Gakkai Zasshi."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnut.2020.00057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T01:20:34Z","timestamp":1588209634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnut.2020.00057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":23,"alternative-id":["10.3389\/fnut.2020.00057"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2020.00057","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"57"}}